blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3290423

EP3290423 - OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.05.2022
Database last updated on 31.08.2024
FormerThe patent has been granted
Status updated on  18.06.2021
FormerGrant of patent is intended
Status updated on  09.02.2021
FormerExamination is in progress
Status updated on  17.04.2020
FormerRequest for examination was made
Status updated on  02.02.2018
Most recent event   Tooltip14.06.2024Lapse of the patent in a contracting state
New state(s): TR		published on 17.07.2024  [2024/29]
Applicant(s)For all designated states
Jiangsu Vcare Pharmatech Co., Ltd
No. 15 Wanshou Road
Pukou Hi-Tech Industrial Development Zone
Nanjing, Jiangsu 210061 / CN
[2018/10]
Inventor(s)01 / SUN, Hongbin
c/o Jiangsu Vcare Pharmatech Co., Ltd
No. 15 Wanshou Road
Pukou Hi- Tech Industrial Development Zone
Nanjing, Jiangsu 210061 / CN
02 / SHAN, Jiaqi
c/o Jiangsu Vcare Pharmatech Co., Ltd
No. 15 Wanshou Road
Pukou Hi- Tech Industrial Development Zone
Nanjing, Jiangsu 210061 / CN
03 / ZHANG, Boyu
c/o Jiangsu Vcare Pharmatech Co., Ltd
No. 15 Wanshou Road
Pukou Hi-Tech Industrial Development Zone
Nanjing, Jiangsu 210061 / CN
04 / YUAN, Fang
c/o Jiangsu Vcare Pharmatech Co., Ltd
No. 15 Wanshou Road
Pukou Hi-Tech Industrial Development Zone
Nanjing, Jiangsu 210061 / CN
 [2018/10]
Representative(s)Lang, Johannes
Bardehle Pagenberg Partnerschaft mbB
Patentanwälte, Rechtsanwälte
Prinzregentenplatz 7
81675 München / DE
[2018/10]
Application number, filing date17172160.828.01.2011
[2018/10]
Priority number, dateCN20101010409102.02.2010         Original published format: CN201010104091
CN20101062432930.12.2010         Original published format: CN201010624329
[2018/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3290423
Date:07.03.2018
Language:EN
[2018/10]
Type: B1 Patent specification 
No.:EP3290423
Date:21.07.2021
Language:EN
[2021/29]
Search report(s)(Supplementary) European search report - dispatched on:EP24.11.2017
ClassificationIPC:C07D495/04, A61K31/4365, A61P7/02
[2018/10]
CPC:
C07D495/04 (EP,KR,US); A61K31/4365 (EP,KR,US); A61K9/08 (KR);
A61K9/14 (KR); A61K9/20 (KR); A61K9/48 (KR);
A61P7/00 (EP); A61P7/02 (EP); A61P9/00 (EP);
A61P9/10 (EP); C07B2200/07 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/10]
TitleGerman:OPTISCH AKTIVE 2-HYDROXY-TETRAHYDROTHIEN-PYRIDIN-DERIVATE, HERSTELLUNGSVERFAHREN UND VERWENDUNG BEI DER MEDIKAMENTENHERSTELLUNG[2018/10]
English:OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF[2018/10]
French:DÉRIVÉS DE 2-HYDROXYTÉTRAHYDROTHIÉNOPYRIDINE OPTIQUEMENT ACTIFS, LEUR PROCÉDÉ DE PRÉPARATION ET UTILISATION DANS LA FABRICATION DE MÉDICAMENT[2018/10]
Examination procedure22.05.2017Examination requested  [2018/10]
22.05.2017Date on which the examining division has become responsible
07.09.2018Amendment by applicant (claims and/or description)
21.04.2020Despatch of a communication from the examining division (Time limit: M02)
19.06.2020Reply to a communication from the examining division
10.02.2021Communication of intention to grant the patent
10.06.2021Fee for grant paid
10.06.2021Fee for publishing/printing paid
10.06.2021Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP11739328.0  / EP2532668
Opposition(s)22.04.2022No opposition filed within time limit [2022/26]
Fees paidRenewal fee
22.05.2017Renewal fee patent year 03
22.05.2017Renewal fee patent year 04
22.05.2017Renewal fee patent year 05
22.05.2017Renewal fee patent year 06
22.05.2017Renewal fee patent year 07
29.01.2018Renewal fee patent year 08
04.12.2018Renewal fee patent year 09
24.12.2019Renewal fee patent year 10
18.01.2021Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.01.2011
AL21.07.2021
AT21.07.2021
CY21.07.2021
CZ21.07.2021
DK21.07.2021
EE21.07.2021
FI21.07.2021
HR21.07.2021
LT21.07.2021
LV21.07.2021
MC21.07.2021
MK21.07.2021
PL21.07.2021
RO21.07.2021
RS21.07.2021
SI21.07.2021
SK21.07.2021
SM21.07.2021
TR21.07.2021
BG21.10.2021
NO21.10.2021
GR22.10.2021
IS21.11.2021
PT22.11.2021
IE28.01.2022
LU28.01.2022
[2024/29]
Former [2024/22]HU28.01.2011
AL21.07.2021
AT21.07.2021
CY21.07.2021
CZ21.07.2021
DK21.07.2021
EE21.07.2021
FI21.07.2021
HR21.07.2021
LT21.07.2021
LV21.07.2021
MC21.07.2021
MK21.07.2021
PL21.07.2021
RO21.07.2021
RS21.07.2021
SI21.07.2021
SK21.07.2021
SM21.07.2021
BG21.10.2021
NO21.10.2021
GR22.10.2021
IS21.11.2021
PT22.11.2021
IE28.01.2022
LU28.01.2022
Former [2024/20]HU28.01.2011
AL21.07.2021
AT21.07.2021
CY21.07.2021
CZ21.07.2021
DK21.07.2021
EE21.07.2021
FI21.07.2021
HR21.07.2021
LT21.07.2021
LV21.07.2021
MC21.07.2021
PL21.07.2021
RO21.07.2021
RS21.07.2021
SI21.07.2021
SK21.07.2021
SM21.07.2021
BG21.10.2021
NO21.10.2021
GR22.10.2021
IS21.11.2021
PT22.11.2021
IE28.01.2022
LU28.01.2022
Former [2024/18]HU28.01.2011
AL21.07.2021
AT21.07.2021
CZ21.07.2021
DK21.07.2021
EE21.07.2021
FI21.07.2021
HR21.07.2021
LT21.07.2021
LV21.07.2021
MC21.07.2021
PL21.07.2021
RO21.07.2021
RS21.07.2021
SI21.07.2021
SK21.07.2021
SM21.07.2021
BG21.10.2021
NO21.10.2021
GR22.10.2021
IS21.11.2021
PT22.11.2021
IE28.01.2022
LU28.01.2022
Former [2023/09]AL21.07.2021
AT21.07.2021
CZ21.07.2021
DK21.07.2021
EE21.07.2021
FI21.07.2021
HR21.07.2021
LT21.07.2021
LV21.07.2021
MC21.07.2021
PL21.07.2021
RO21.07.2021
RS21.07.2021
SI21.07.2021
SK21.07.2021
SM21.07.2021
BG21.10.2021
NO21.10.2021
GR22.10.2021
IS21.11.2021
PT22.11.2021
IE28.01.2022
LU28.01.2022
Former [2022/46]AL21.07.2021
AT21.07.2021
CZ21.07.2021
DK21.07.2021
EE21.07.2021
FI21.07.2021
HR21.07.2021
LT21.07.2021
LV21.07.2021
MC21.07.2021
PL21.07.2021
RO21.07.2021
RS21.07.2021
SI21.07.2021
SK21.07.2021
SM21.07.2021
BG21.10.2021
NO21.10.2021
GR22.10.2021
IS21.11.2021
PT22.11.2021
LU28.01.2022
Former [2022/39]AL21.07.2021
AT21.07.2021
CZ21.07.2021
DK21.07.2021
EE21.07.2021
FI21.07.2021
HR21.07.2021
LT21.07.2021
LV21.07.2021
MC21.07.2021
PL21.07.2021
RO21.07.2021
RS21.07.2021
SI21.07.2021
SK21.07.2021
SM21.07.2021
BG21.10.2021
NO21.10.2021
GR22.10.2021
IS21.11.2021
PT22.11.2021
Former [2022/29]AL21.07.2021
AT21.07.2021
CZ21.07.2021
DK21.07.2021
EE21.07.2021
FI21.07.2021
HR21.07.2021
LT21.07.2021
LV21.07.2021
PL21.07.2021
RO21.07.2021
RS21.07.2021
SI21.07.2021
SK21.07.2021
SM21.07.2021
BG21.10.2021
NO21.10.2021
GR22.10.2021
IS21.11.2021
PT22.11.2021
Former [2022/25]AT21.07.2021
CZ21.07.2021
DK21.07.2021
EE21.07.2021
FI21.07.2021
HR21.07.2021
LT21.07.2021
LV21.07.2021
PL21.07.2021
RO21.07.2021
RS21.07.2021
SK21.07.2021
SM21.07.2021
BG21.10.2021
NO21.10.2021
GR22.10.2021
IS21.11.2021
PT22.11.2021
Former [2022/24]AT21.07.2021
CZ21.07.2021
DK21.07.2021
EE21.07.2021
FI21.07.2021
HR21.07.2021
LT21.07.2021
LV21.07.2021
PL21.07.2021
RO21.07.2021
RS21.07.2021
SK21.07.2021
BG21.10.2021
NO21.10.2021
GR22.10.2021
IS21.11.2021
PT22.11.2021
Former [2022/21]AT21.07.2021
DK21.07.2021
FI21.07.2021
HR21.07.2021
LT21.07.2021
LV21.07.2021
PL21.07.2021
RS21.07.2021
BG21.10.2021
NO21.10.2021
GR22.10.2021
IS21.11.2021
PT22.11.2021
Former [2022/11]AT21.07.2021
FI21.07.2021
HR21.07.2021
LT21.07.2021
LV21.07.2021
PL21.07.2021
RS21.07.2021
BG21.10.2021
NO21.10.2021
GR22.10.2021
IS21.11.2021
PT22.11.2021
Former [2022/09]AT21.07.2021
FI21.07.2021
LT21.07.2021
RS21.07.2021
BG21.10.2021
NO21.10.2021
PT22.11.2021
Former [2022/08]AT21.07.2021
FI21.07.2021
LT21.07.2021
BG21.10.2021
NO21.10.2021
Former [2022/07]AT21.07.2021
LT21.07.2021
NO21.10.2021
Documents cited:Search[I]EP0421861  (SANOFI SA [FR]) [I] 1-9 * page 4, line 43 - page 5, line 14 * * page 9; example 19 * * page 18, lines 22-28 *;
 [A]CN101591344  (LIANYUNGANG HENGBANG PHARMACEU [CN]) [A] 1-9 * abstract ** claims 1-6 *
by applicantUS5190938
 WO9749397
 US5874581
    - LANCET, (1996), vol. 348, page 1329
    - THROMB HAEMOST, (2000), vol. 84, page 891
    - J PHARMACOL EXP THER, (2006), vol. 319, page 1467
    - CARDIOVASCULAR DRUG REVIEWS, (1993), vol. 11, page 180
    - CIRCULATION, (2004), vol. 109, page 166
    - N ENGL J MED, (2007), vol. 357, page 2001
    - NATURE, (1962), vol. 194, no. 4832, page 927
    - DRUG METAB REV, (2005), vol. 37, no. 2, page 99
    - DRUG METAB DISP, (2002), vol. 30, page 1288
 CN20081097756
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.